New York City, NY -- (SBWIRE) -- 01/31/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: J.C. Penney Company, Inc. (NYSE:JCP), Applied Micro Circuits Corporation (NASDAQ:AMCC), Generex Biotechnology Corporation (OTCMKTS:GNBT), Citrix Systems, Inc. (NASDAQ:CTXS)
J.C. Penney Company, Inc. (NYSE:JCP) declined -8.27%, trading on 55.91 million shares, to end the trade at $5.77. If we look at its trading history of the past 52 weeks, the share price suffered a low of $5.69 and was moved to the maximum level of $23.10. The stock changed hands in a range of $5.69 to $6.38, bringing its market capitalization to about $1.76 billion. J. C. Penney Company, Inc. is a holding company whose principal operating subsidiary is J. C. Penney Corporation, Inc. (JCP). The Company’s business consists of selling merchandise and services to consumers through its department stores and through its Internet Website at jcp.com.
Will JCP Get Buyers Even After The Recent Rally? Find Out Here
Applied Micro Circuits Corporation (NASDAQ:AMCC) declined -8.24%, to complete the trading session at $9.91, with a total volume of 2.93 million shares. The stock, on average, trades on a volume of 1.18 million shares. In the past 52 weeks, the share price has not declined below $6.51 and above $15.09. It floated in a range of $9.90 to $10.95 during the last trading session, with a beta value of 1.37. Its market capitalization now moved to about $735.09 million. Applied Micro Circuits Corporation (AMCC) is a global computing and connectivity solutions for data centers and service providers. The Company operates in two segments: Computing and Connectivity. The Company’s products include the X-Gene ARM 64 bit Server on a Chip solution, along with the X-WeaveTM family of connectivity products, for cloud/hyperscale data center and enterprise applications. X-Weave products segments including 10, 40, and 100 gigabit per second (Gbps) solutions serving data center and service provider market opportunities.
Will AMCC Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) recorded a fall of -8.06% and was in a range of $0.04-$0.05 before closing at $0.0422. The share price hit its 52-week low of $0.02 and $0.07 was the best price. The stock completed the day with a total volume of 6.10 million shares, versus an average volume of 8.47 million shares. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
Is it the Right to Grab GNBT after the Recent Slump? Get Free Trend Analysis Here
Citrix Systems, Inc. (NASDAQ:CTXS) declined -7.48% yesterday, bringing its market capitalization around $9.93 billion. The total number of shares that changed hands during the session was 18.15 million shares, as compared to average trading volume of 2.52 million shares. The share price, after opening at $51.53, made a high of $53.63 and hovered above $51.18 to end the day at $53.29. Citrix Systems, Inc. is a cloud computing company. The Company designs, develops and markets technology solutions that enable information technology (IT) services. The Enterprise division and the Online Services division constitute its two segments. Its revenues are derived from sales of Enterprise division products, which include its Desktop Solutions, Datacenter and Cloud Solutions, Cloud-based Data Solutions and related technical services and from its Online Services division's Web collaboration, remote access and support services.
Will CTXS Reach the Bottom after Yesterday’s Correction? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)